Animal Core
Animal Core
批准号:
10549478
负责人:
Stephen Mark Tompkins
金额:
$39.03万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-21 至 2028-05-31
关键词:
2019-nCoVAnimal ExperimentationAnimal ModelAnimalsAntibodiesAntibody TherapyB-LymphocytesBiological AssayCattleCommunitiesCoronavirusCoronavirus InfectionsDataDiseaseDoctor of PhilosophyFerretsGoalsHamstersHealthHousingHumanImmuneImmunityImmunological ModelsIndividualInfectionMerbecovirusMiddle East Respiratory Syndrome CoronavirusModelingMonoclonal AntibodiesMusNational Institute of Allergy and Infectious DiseaseOutcomePliabilityProductivityProtocols documentationRNA vaccinationResearchResearch PersonnelResearch Project GrantsResourcesRespiratory Tract InfectionsRunningSARS coronavirusSARS-CoV-2 variantSamplingSarbecovirusSerumServicesTestingTherapeutic Monoclonal AntibodiesTherapeutic antibodiesTransgenic MiceUniversitiesVaccinationVaccine TherapyVaccinesVariantVeterinary MedicineViralVirusWorkanimal coronavirusanimal resourcebetacoronavirusbetacoronavirus vaccinecollegecoronavirus diseasecoronavirus vaccinationcoronavirus vaccineeffectiveness evaluationefficacy evaluationefficacy studyexperiencehigh riskhuman diseaseimmunological diversityimprintimprovedinnovationlead candidatemeetingsneutralizing monoclonal antibodiesnovelnovel coronaviruspathogenpre-clinical assessmentpreventprogramsrespiratory virusresponseseasonal coronavirussuccesssynergismtherapeutic candidatetooltraining opportunitytransmission processuniversal coronavirus vaccinevaccine candidatevaccine developmentvaccine efficacyvaccine-induced antibodiesvirus resource
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary/Abstract
Robust animal models of coronavirus infection are required for pre-clinical assessment of candidate vaccines
and therapeutic antibodies to prevent coronavirus infection and disease. The goal of the Animal Model Core
is to provide a central resource of animal models and virological tools to assess the effectiveness of vaccines
and antibody therapies against betacoronaviruses in multiple animal models of infection. An experienced team
of investigators will utilize established hamster, mouse, and ferret models of betacoronavirus infection to
determine the efficacy of candidate therapeutic monoclonal antibodies (mAbs) developed by Project 1 and
vaccines developed by Project 2. Pre-immune and transmission models will be utilized to stringently test the
lead candidate vaccines. The Animal Model Core will also establish novel animal infection models with SARS-
CoV-2 variant viruses, and a novel ferret model of OC43 embecovirus infection. The Animal Model Core will
also complete virus neutralization assays for SARS-CoV and MERS CoV for all PLUTO investigators,
centralizing resources for these viruses, eliminating redundant biosafety and Select Agent approvals. The
Animal Model Core will serve as an innovative resource to assess efficacy of leading vaccine and mAb
candidates for the PLUTO program through the following three Specific Aims. 1) Establish and maintain
animal models of sarbecovirus and merbecovirus infection. 2) Establish and maintain coronavirus pre-immune
animal models. 3) Expand and improve animal models of embecovirus and sarbecovirus infection. These
complementary aims will enable rigorous assessment of vaccines and mAbs developed by the PLUTO
Projects and develop new animal models of betacoronavirus infection for the project and respiratory virus
research community. The novel pre-immune models will also provide data and samples to improve
understanding of the impact of pre-existing betacoronavirus immunity on subsequent vaccination and infection.
The outcomes of the Animal Model Core will have a positive impact on the success of the PLUTO program
and provide novel information and research tools for the broader research community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunobiology of Influenza Virus Infection: Vaccinating against an evolving virus
-
批准号:7675146
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2009
-
负责人:Stephen Mark Tompkins
-
依托单位:
海外基金